Effect of Shenfu Injection on Antishock and Postoperative Cognitive Impair in Patients with Hemorrhagic Shock

Effect of Shenfu Injection on Antishock and Postoperative Cognitive Impair in Patients with Hemorrhagic Shock: A randomized control clinical trial

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100050242

Enrollment

Unknown

Registered

2021-08-24

Start date

2021-09-01

Completion date

Unknown

Last updated

2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative outcomes

Interventions

experimental group:When the patient had hemorrhagic shock during the operation, shenfu injection 50ml was given on the basis of fluid resuscitation

control group:Only fluid resuscitation is performed when the patient has hemorrhagic shock during surgery

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Voluntary signed informed consent; 2. Aged from 18 to 80 years; 3. Femoral shaft fracture open reduction patients; 4. Combined spinal-epidural anesthesia.

Exclusion criteria

Exclusion criteria: 1. Severe cardiopulmonary dysfunction; 2. Disturbance of consciousness or poor compliance with the completion of the study; 3. ASA Level 4 or above; 4. The patient is participating in other clinical trials within 1 month.

Design outcomes

Primary

Measure	Time frame
incidence of postoperative delirium;	—

Secondary

Measure	Time frame
incidence of non-postoperative delirium;length of hospital stay;all cause mortality within 30 days;	—

Countries

China

Contacts

Public ContactZhang Weiliang

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

hezhangweiliang@163.com+86 13365316885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026